Related Experiment Video
Updated: Feb 28, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
A case of fulminant subacute sclerosing panencephalitis presenting with acute myoclonic-astatic epilepsy
Fabio Magurano1, Gian Luca Marella2, Antonella Marchi1
1Laboratorio Nazionale di Riferimento per il Morbillo e la Rosolia, Dipartimento di Malattie Infettive, Istituto Superiore di Sanità, Rome, Italy.
Abstract:
The neurologic sequelae post-measles are less common than other complications measles-related and can lead to severe disability or death: primary measles encephalitis (PME), acute post-infectious measles encephalomyelitis (APME), measles inclusion body encephalitis (MIBE), and subacute sclerosing panencephalitis (SSPE). SSPE syndrome can affect people years from the acute measles virus infection, as result of the persistence of defective viral particles in brain cells. Clinical onset typically manifests with progressive intellectual deterioration, behavioral changes, and myoclonic jerks. The course of SSPE in the majority of affected children is that of a progressive worsening with fatal outcome within two years. This report described an Italian case of fulminant SSPE syndrome that led to death within few months from the initial onset.
Insights
Subacute sclerosing panencephalitis (SSPE) is a rare, fatal neurologic sequela of measles. This report details a fulminant Italian case of SSPE, resulting in death within months.
Area of Science:
- Neurology
- Virology
- Pediatrics
Background:
- Measles infection can lead to rare but severe neurologic sequelae, including subacute sclerosing panencephalitis (SSPE).
- SSPE arises from persistent defective measles virus particles in brain cells, years after initial infection.
- Typical SSPE presentation involves intellectual decline, behavioral changes, and myoclonic jerks, often leading to death within two years.
Observation:
- This report describes an unusual case of fulminant SSPE in an Italian patient.
- The patient experienced rapid disease progression, leading to death within months of symptom onset.
Findings:
- The case highlights the potential for extremely rapid and fatal progression of SSPE.
- This presentation deviates from the typical slower, progressive course of the disease.
Implications:
- This case underscores the importance of measles vaccination to prevent SSPE.
- Further research may be needed to understand the factors contributing to fulminant SSPE presentations.
- Clinicians should be aware of the possibility of rapid SSPE progression, even in vaccinated populations if immunity wanes.
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

